This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Schrödinger Suite | |
|---|---|
| Name | Schrödinger Suite |
| Developer | Schrödinger, Inc. |
| Released | 1990s |
| Programming language | C++ / Python |
| Operating system | Linux / macOS / Windows |
| License | Proprietary |
Schrödinger Suite
Schrödinger Suite is a commercial molecular modeling and computational chemistry software platform developed by Schrödinger, Inc. for structure-based design, molecular dynamics, and cheminformatics. Intended for pharmaceutical, biotechnology, and academic research, the suite integrates quantum chemistry, molecular mechanics, and visualization tools to support lead discovery, lead optimization, and materials design workflows. It interoperates with external packages and databases to enable end-to-end computational pipelines for small molecules, peptides, and biologics.
The suite combines modules for ligand docking, protein modeling, free-energy calculations, and quantum mechanics, and is often used alongside packages and services such as Gaussian (software), AMBER (software), GROMACS, CHARMM, and NAMD. Academic groups and industrial teams from organizations including Pfizer, Novartis, Roche, AstraZeneca, and Merck have published workflows using the platform, and it features integrations with data resources like Protein Data Bank, ChEMBL, PubChem, and UniProt. The platform supports scripting with languages and tools such as Python (programming language), Jupyter Notebook, Conda, and Docker to enable reproducible pipelines across high-performance computing clusters and cloud providers like Amazon Web Services, Google Cloud Platform, and Microsoft Azure.
Major components include a docking engine, a molecular mechanics engine, a quantum chemistry interface, an automated lead-optimization pipeline, and visualization applications. Specific modules often cited in literature and practice include a high-throughput docking application comparable in role to AutoDock Vina and Glide (docking tool), free-energy perturbation modules akin to FEP+ and alchemical transformation tools, and quantum modules designed to interoperate with Jaguar (quantum chemistry) and external ab initio packages. The suite interfaces with cheminformatics toolkits such as RDKit, OpenEye (software), and ChemAxon products, and supports file formats familiar from PDB (file format), SDF (file format), and SMILES notation.
The platform offers ligand and receptor preparation, flexible docking, induced-fit modeling, protein-ligand scoring, and molecular dynamics refinement. Advanced features include binding free energy estimation, enhanced sampling, and hybrid quantum mechanics/molecular mechanics (QM/MM) calculations used in publications alongside methods like DFT (density functional theory), MP2, and Hartree–Fock. Visualization and analysis are supported via graphical tools analogous to PyMOL, VMD (software), and integrations with cheminformatics databases such as BindingDB, ZINC (database), and DrugBank. The suite supports parallelization strategies compatible with schedulers and resource managers like SLURM, LSF (software), and Torque (software).
Researchers apply the suite to structure-based drug design, virtual screening, fragment-based lead discovery, and antibody engineering projects. Case studies span targets and disease areas associated with organizations and consortia including NIH, Wellcome Trust, Bill & Melinda Gates Foundation, and collaborations with academic institutions such as Harvard University, Massachusetts Institute of Technology, Stanford University, University of Cambridge, and University of Oxford. Industrial applications include hit-to-lead optimization at companies like Bayer, Johnson & Johnson, Sanofi, and GlaxoSmithKline, and materials science projects in partnership with laboratories at Lawrence Berkeley National Laboratory and Oak Ridge National Laboratory.
Schrödinger, Inc. distributes the suite under proprietary commercial licenses with options for academia, industry, and government labs. Licensing models include site licenses, node-locked licenses, and cloud-based subscriptions compatible with procurement and compliance frameworks used by institutions such as NIH, DARPA, and European Commission research programs. Training and certification programs are offered through corporate channels and partnerships with professional societies like the American Chemical Society and educational programs at universities including Columbia University and Johns Hopkins University.
The software evolved from early molecular modeling efforts in the 1990s to modern releases integrating GPU acceleration and scalable cloud workflows. Development milestones reference advances in docking accuracy, free-energy algorithms, and QM/MM integration, and parallel developments in the field by groups behind AutoDock, Rosetta (software), Schrödinger (company) founders and academic labs at Weill Cornell Medicine and Scripps Research. Versioning and feature roadmaps have been presented at conferences such as Gordon Research Conferences, American Chemical Society National Meeting, BIO International Convention, and ISMB.
The platform has been cited in peer-reviewed studies across medicinal chemistry, chemical biology, and computational physics journals including work affiliated with institutions like Cambridge University Hospitals, Imperial College London, Yale University, University of California, San Francisco, and ETH Zurich. It has influenced drug discovery pipelines at pharma leaders such as Eli Lilly, Bristol-Myers Squibb, and Amgen, and contributed to industry-academia collaborations funded by organizations including Wellcome Trust and European Research Council. Reviews and benchmarking studies compare its modules to alternatives such as AutoDock Vina, GOLD (software), Rosetta, and CHARMM tools, informing purchasing and methodology decisions in both industry and academia.
Category:Computational chemistry software